Speech Accessibility Project

NCT ID: NCT05889260

Last Updated: 2025-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

485 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-15

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the Speech Accessibility Project at the University of Illinois Beckman Institute (https://speechaccessibilityproject.beckman.illinois.edu) is to collect, annotate, and curate a shared database of speech samples from people with atypical speech, and share this data set with researchers at other organizations. This two-year project plans to collect 1,200,000 speech samples from 2,000 people, each of whom will provide 600 samples. In Year 1, the initial focus will be people with Parkinson's. In Year 2, four more etiologies of interest will be recruited: Amyotrophic Lateral Sclerosis (ALS), Cerebral Palsy (CP), Down Syndrome (DS), and Stroke. UIUC will build an open-source software infrastructure to collect annotated speech samples and share these data in an appropriately secure fashion with researchers from our partner technology companies (and eventually, other organizations as well) so that they can use these data to improve their automatic speech recognition algorithms. This project promotes diversity, equity, and inclusion by helping technology companies to fully support all types of speech, and it is also more efficient and less burdensome for these specialized patient populations to have one centralized "collector" of speech samples.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of our project is to collect 1,200,000 speech samples from 2,000 people with dysarthria, where we expect to collect data from 400 people each from five different patient populations. Each person would provide 600 speech samples.

(600 samples/person x 400 persons/etiology x 5 etiologies = 1,200,000 samples)

Our schedule of research procedures is:

1. February or March-August 2023: data collection of speech samples from 400 people with Parkinson's.
2. August 2023-August 2025: data collection of speech samples from 1,600 people with ALS, CP, DS, and Stroke.

Data collection of speech samples in Year 1 will be a collaboration of the University of Illinois and of mentors from Lee Silverman Voice Therapy (LSVT) Global. Potential participants will be screened both with a questionnaire and by providing a short set of "quality control" speech samples. If the participant does not pass screening, they will be thanked for their interest. Otherwise, the participant is eligible for the study and can do the informed consent process and then engage in contributing speech samples.

Participants can do as many recordings as they wish at whatever time of day is convenient for them. Participants will be able to login to the system at any time, 24/7.

In Year 2, this procedure will be performed with patients from other etiologies with additional advocacy organizations as partners.

Participants who are unable to read text from the computer screen will be offered the opportunity to record speech using a verbal-repetition protocol. In order to participate in the verbal repetition protocol, a participant must be accompanied by a caregiver who is also willing to be recorded. If a participant agrees to this protocol, then the caregiver will read each prompt to the participant. The participant will then repeat the words spoken by the caregiver, or respond to any question asked by the caregiver.

Participants also have the option to provide additional data about themselves, such as their age, race and ethnicity, and the year of their diagnosis. These "metadata tags" are completely optional but are helpful for analysis.

The collected speech samples will be stored securely in a custom database built by the UIUC Beckman Institute. All samples are stored with a unique participant ID code. All samples are annotated by our UIUC research team with technical information about the acoustic waveform and other information.

The entire database of speech samples will be shared with our coalition partners (Amazon, Apple, Google, Meta, and Microsoft), and, after all data collection is complete, with other universities and companies who are willing to sign our data use agreement. Each partner has signed a data use agreement with UIUC that allows these deidentified data to be used for improvements in speech recognition technology and assures the privacy of participants and confidentiality of data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease Progressive Supranuclear Palsy Multiple System Atrophy Dementia With Lewy Bodies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (age \>= 18 years)
* Self-reported diagnosis of Parkinson's Disease, ALS, CP, DS, or Stroke
* Reads and speaks English in the form of complete sentences
* Has a valid email address
* Ability to access web browser to participate in study

Exclusion Criteria

* Is a resident of the State of Washington, Texas, or Illinois (because these states have privacy laws that would not allow us to collect 'voice prints')
* If quality control screening of initial speech samples "fails" because of poor data quality (e.g., poor quality recording environment, or person's speech is "too typical" and not sufficiently interesting to continue collecting)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LSVT Global

UNKNOWN

Sponsor Role collaborator

Amazon, Inc.

INDUSTRY

Sponsor Role collaborator

Apple Inc.

INDUSTRY

Sponsor Role collaborator

Google LLC.

INDUSTRY

Sponsor Role collaborator

Meta Platforms, Inc.

UNKNOWN

Sponsor Role collaborator

Microsoft Corporation

INDUSTRY

Sponsor Role collaborator

University of Illinois at Urbana-Champaign

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark A Hasegawa-Johnson, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Illinois at Urbana-Champaign

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LSVT Global

Denver, Colorado, United States

Site Status

University of Illinois at Urbana-Champaign

Urbana, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://speechaccessibilityproject.beckman.illinois.edu/

Project information and contact information

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23183

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Colorado Oral Strengthening Device
NCT05464225 COMPLETED NA